Court Bars SRU From Using or Selling Infringed Optical Biosensors Licensed to Corning | GenomeWeb

NEW YORK, March 10 (GenomeWeb News) - The United States District Court for the District of Delaware has concluded that Corning is entitled to a permanent injunction against SRU Biosystems, which infringed a patent for optical biosensors, Corning said yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.